Government / Health & Medical / Health Wellness / Health, Policy & Regulation / Mental Health / Public Health
The Adderall Shortage Is Getting Worse in the Ways That Matter Most
The ongoing Adderall shortage, now in its fourth year, continues to worsen despite a DEA production quota increase. Structural issues in supply chains, pharmaceutical exits from the generic market, and a high demand fueled by telehealth prescriptions contribute to the crisis. Patients resort to unsafe alternatives, highlighting the inadequacy of regulatory responses.
